asa glp 1 guidelines GLP-1 RA guidance roundup GLP-1 medications safe to continue

A deficiency in GLP-1 in humans is a primary cause of type 2 diabetes and there are similarities in how exendin and GLP-1 work

Journal reference: Abbasi et al

Reconstitution is needed prior to use to make the albiglutide solution of 60 mg/ml or 100 mg/ml for injection

Studies have found that GLP-1RA have similar effects in alleviating osteoporosis and preventing fractures (Nuche-Berenguer et al., 2010

Top Key Players Sun Pharmaceutical Industries Ltd Sanofi Pfizer.Inc Novo-Nordisk A/S Eli Lilly and Company Boehringer Ingelheim International GmbH AstraZeneca Amylyx Pharmaceuticals Recent Developments In July 2024, Amylyx Pharmaceuticals strategically acquired Avexitide, a promising GLP-1 receptor agonist, from Eiger Biopharmaceuticals

7 Conclusions Obesity increases the risk of microvascular and macrovascular complications, various types of cancer, and overall mortality in patients with T1D